School of Pharmacy Caps Academic Year with New Dean, Stellar Class of 2013
The nation's premier pharmacy school capped its academic year by welcoming a new dean and celebrating a stellar class of graduates at its commencement ceremony on May 24.
University of California San Francisco
Give to UCSF
Simple Two-Drug Combination Proves Effective in Reducing Risk of Stroke
Results of a Phase III clinical trial showed that a simple drug regimen of two anti-clotting drugs lowered the risk of stroke by almost one-third, compared to aspirin alone, when given to patients who had minor or transient stroke symptoms to prevent subsequent attacks.
Aspirin May Fight Cancer by Slowing DNA Damage
Aspirin is known to lower risk for some cancers, and a new UCSF-led study points to a possible explanation, with the discovery that aspirin slows the accumulation of DNA mutations in abnormal cells in at least one pre-cancerous condition.
Trial Buster
Pharmacologist Lisa Bero, PhD, answers our questions about industry bias in clincial trials.
Howard Hughes Medical Institute Names Two UCSF Scientists as New Investigators
Two UCSF scientists — brain researcher Michael Brainard, PhD, and cell biologist Dyche Mullins, PhD — have been selected to be Howard Hughes Medical Institute investigators.
Antidepressants Linked with Increased Risks After Surgery
Some of the most widely prescribed antidepressant medications are associated with increased risk of bleeding, transfusion, hospital readmission and death when taken around the time of surgery, according to an analysis co-led by UCSF.
